GREENVILLE, S.C. & BURLINGTON, Mass.--(BUSINESS WIRE)--Quantros, Inc., the healthcare industry’s leading provider of enterprise safety risk management, quality management and performance analytics solutions, and Nuance Communications, Inc. (Nasdaq: NUAN), jointly announced the results of a study that showed significant quality improvement for hospitals implementing Nuance’s clinical documentation improvement (CDI) solutions. Using Quantros’ CareChex® hospital quality ratings methodology, the study specifically focused on measures of Observed to Expected Mortality, as these are most aligned with proper identification of a patient’s principal diagnosis and patient severity changes reflected in clinical documentation.
Findings show:
- 93 percent of Nuance clients are in the top 50 percent of CareChex overall mortality ratings of U.S. hospitals, and exceeded national benchmarks for mortality rating performance.
- 36 percent of Nuance CDI clients are in the top 10 percent of hospitals in analysis of CareChex overall mortality rating performance
- Hospitals that deploy Nuance’s CDI program see significant improvement in quality ratings post implementation, including up to two times improvement on mortality ratings, and up to seven times improvement on expected mortality ratings.
“In the emerging value-based healthcare economy, payments and reimbursement are inextricably linked to the quality of care that is delivered, documented and measured,” explains Shane Wolverton, senior vice president corporate development, Quantros. “Winners in this new climate will be the organizations that accurately capture and report performance on a multitude of quality measures and performance indicators, and which are not sufficiently reconcilable through the lens of coding metrics or case mix index (CMI) alone.”
CareChex® is an innovative medical quality rating system designed to assist providers and purchasers in evaluating the quality of inpatient care using a patent pending quality scoring system which integrates the most reliable quality indicators available in the industry into a single, multi-dimensional, composite score and rating. Relying on both public and proprietary measures of performance, CareChex® compares the quality of hospital and physician care to national and state standards using a variety of clinical indicators to assign a proprietary Composite Quality Score and Rating. Unlike other rating systems, CareChex® provides a multidimensional, integrated analysis of medical quality and incorporates seven peer-reviewed methodologies which address key components of the quality of inpatient care.
“The implementation of our clinically-focused CDI program combined with CareChex® analytics affords hospitals an even stronger and more realistic severity-adjusted view of the quality of care delivered to patients in value-based care models,” said Anthony Oliva, vice president and chief medical officer, Nuance. “Hospitals need data to know where to focus their efforts -- where they need quality improvement and how much of that is a physician documentation problem. One impactful way to remove the noise and pinpoint where to focus is through a CDI program that is clinically focused.”
More information about the CareChex® Hospital Quality Ratings is available at http://www.carechex.com. For more information on Nuance CDI solutions, visit Nuance booth #421 at The Healthcare Financial Management Association (HFMA) National Institute, Las Vegas June 26-29, 2016, Las Vegas, Nevada.
About Quantros, Inc.
Quantros is a leading provider of software and services to advance healthcare quality and safety performance. Our Software-as a-Service (SaaS)-based applications help thousands of hospitals, retail pharmacies and some of the nation’s largest health systems to capture actionable intelligence they can use to improve outcomes, reduce risks and to reinforce their commitments to delivering safer, higher-quality value-based care. For more information, visit http://www.quantros.com or follow us on Twitter @Quantros.
About Nuance Communications, Inc.
Nuance Communications, Inc. (NASDAQ: NUAN) is a leading provider of voice and language solutions for businesses and consumers around the world. Its technologies, applications and services make the user experience more compelling by transforming the way people interact with devices and systems. Every day, millions of users and thousands of businesses experience Nuance’s proven applications. For more information, please visit www.nuance.com/healthcare.Connect with Nuance on social media through the healthcare blog, What’s next, as well as LinkedIn, and Twitter.
Nuance and the Nuance logo are trademarks or registered trademarks of Nuance Communications, Inc. or its affiliates in the United States and/or other countries. All other company names or product names may be the trademarks of their respective owners.
The statements in this press release relating to future plans, events or services, are forward-looking statements which are subject to specific risks and uncertainties. There are a number of factors which could cause actual events or results to differ materially from those indicated in such forward looking statements, including fluctuations in demand for the Nuance products, and the continued development of Nuance products. The reader is warned not to rely on these forward-looking statements without reservation, since these are simply reflections of the current situation. Nuance disclaims any obligation to update any forward-looking statements as a result of developments occurring after the date of this document.
